Janus Investment Fund. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Eli Lilly & Co.LLY | 9.41% | $546.44M | 455,585 |
| Johnson & JohnsonJNJ | 7.09% | $411.81M | 1,621,482 |
| AstraZeneca plc | 3.93% | $302.85M | 1,219,979 |
| AbbVie, Inc.ABBV | 4.67% | $271.02M | 1,077,025 |
| UnitedHealth Group, Inc.UNH | 4.54% | $263.63M | 634,279 |
| Revolution Medicines, Inc.RVMD | 3.02% | $175.40M | 936,558 |
| Argenx SEARGX | 2.63% | $152.70M | 164,585 |
| Novartis AGNVS | 2.56% | $148.84M | 949,726 |
| Roche Holding AG | 2.01% | $144.75M | 283,990 |
| Thermo Fisher Scientific, Inc.TMO | 2.33% | $135.41M | 270,088 |
| Praxis Precision Medicines, Inc.PRAX | 2.19% | $127.00M | 379,352 |
| Bridgebio Pharma, Inc.BBIO | 2.04% | $118.45M | 1,590,382 |
| CVS Health Corp.CVS | 2.02% | $117.16M | 1,132,543 |
| Intuitive Surgical, Inc.ISRG | 1.94% | $112.90M | 283,906 |
| Merck & Co., Inc.MRK | 1.87% | $108.84M | 847,026 |
| Abbott LaboratoriesABT | 1.86% | $108.26M | 1,193,133 |
| Sanofi SA | 1.58% | $104.90M | 1,074,188 |
| Vertex Pharmaceuticals, Inc.VRTX | 1.69% | $98.28M | 197,846 |
| Ascendis Pharma A/S | 1.68% | $97.47M | 365,445 |
| Danaher Corp.DHR | 1.65% | $95.71M | 502,471 |
| Amgen, Inc.AMGN | 1.64% | $95.14M | 262,742 |
| Stryker Corp.SYK | 1.41% | $82.01M | 260,477 |
| PTC Therapeutics, Inc.PTCT | 1.40% | $81.21M | 995,577 |
| Gilead Sciences, Inc.GILD | 1.39% | $80.53M | 637,400 |
| Travere Therapeutics, Inc.TVTX | 1.38% | $80.28M | 1,413,117 |
| Madrigal Pharmaceuticals, Inc.MDGL | 1.34% | $78.05M | 145,364 |
| HCA Healthcare, Inc.HCA | 1.26% | $73.46M | 188,403 |
| Mirum Pharmaceuticals, Inc.MIRM | 1.13% | $65.44M | 558,993 |
| Boston Scientific Corp.BSX | 1.12% | $65.34M | 1,530,844 |
| Teva Pharmaceutical Industries Ltd. | 1.10% | $63.80M | 1,883,103 |
| United Therapeutics Corp.UTHR | 1.07% | $62.20M | 114,790 |
| Elevance Health, Inc.ELV | 1.04% | $60.56M | 156,583 |
| Globus Medical, Inc.GMED | 1.01% | $58.82M | 744,421 |
| Lantheus Holdings, Inc.LNTH | 0.97% | $56.41M | 508,445 |
| McKesson Corp.MCK | 0.96% | $55.77M | 73,813 |
| Vaxcyte, Inc.PCVX | 0.94% | $54.79M | 942,493 |
| Dyne Therapeutics, Inc.DYN | 0.87% | $50.48M | 2,272,649 |
| Edwards Lifesciences Corp.EW | 0.78% | $45.31M | 500,885 |
| Medtronic plc | 0.74% | $42.99M | 549,586 |
| Janus Henderson Cash Liquidity Fund LLCCash or money market | 0.70% | $40.50M | 40,502,386 |
| UCB SA | 0.58% | $38.66M | 112,992 |
| Cencora, Inc.COR | 0.60% | $34.88M | 123,277 |
| Medline, Inc.MDLN | 0.58% | $33.57M | 851,191 |
| Definium Therapeutics, Inc.DFTX | 0.58% | $33.41M | 710,241 |
| Insmed, Inc.INSM | 0.56% | $32.58M | 305,544 |
| Dexcom, Inc.DXCM | 0.54% | $31.12M | 462,075 |
| Structure Therapeutics, Inc.GPCR | 0.51% | $29.48M | 549,353 |
| Spyre Therapeutics, Inc.SYRE | 0.50% | $29.17M | 328,592 |
| Ideaya Biosciences, Inc.IDYA | 0.49% | $28.24M | 757,659 |
| Glaukos Corp.GKOS | 0.47% | $27.53M | 196,973 |